Home About Us Research Biotechnology Education Facilities Press Releases Location Contact Us Careers
Building for Discovery
The Pennsylvania Biotechnology Center of Bucks County is the result of a unique partnership to create an historic and transformational force from which discoveries will be born, students will be trained, and new companies will be launched.
A range of options are available to accommodate your company at the Pennsylvania Biotechnology Center, from a single lab or office to 3,000 square feet of custom designed space to a 6,000 square foot production facility. Learn more about our facilities and resources.
In The News
Michael J. Sofia, Ph.D. announced as winner of Pennsylvania Bio's 2014 Scientific Achievement Award.
Michael J. Sofia, Ph.D., President, CSO and Co-Founder of OnCore Biopharma, Inc., was announced as the winner of Pennsylvania Bio's 2014 Scientific Achievement Award. Dr. Sofia will be honored at Pennsylvania Bio's Annual Dinner and Awards Celebration March 12 at the Pennsylvania Convention Center in Philadelphia. Read more.
7th Annual Holiday Food Drive Sponsored by the Hepatitis B Foundation and PA Biotechnology Center
The Hepatitis B Foundation and Pennsylvania Biotechnology Center are doing their part by collecting non-perishable food items for the Bucks County Housing Group food pantry. Read more.
KannaLife Sciences, Inc. Signs Materials Transfer and Testing Agreement with Baruch S. Blumberg Institute
KannaLife Sciences, Inc. Signs Materials Transfer and Testing Agreement with Baruch S. Blumberg Institute WEST HILLS, N.Y., Dec. 20, 2013 - KannaLife Sciences, Inc. ("KannaLife") announces that it has entered into a Materials Transfer and Testing Agreement with the Natural Product Discovery Institute (NPDI), a division of the Baruch S. Blumberg Institute (BSBI), to provide KannaLife with access to a collection of more than 100,000 extracts from plants, fungi, and bacteria, previously owned by Merck and donated to the Institute. Read more.
RBC Biotech Conference - “Consumer Product Development, an Alternative Path to Commercialization"
The 13th Annual RBC Biotech Conference was held on Friday, November 15, 2013. Company leaders gathered at the PA Biotechnology Center to discuss ways to get products to market faster, saving valuable time and money during the process. Read more.
Hepatitis B Foundation’s Research Institute Renamed for Nobel Prize Winner Dr. Baruch S. Blumberg
Oct. 7 - The Hepatitis B Foundation officially renamed its research institute the "Baruch S. Blumberg Institute" in a grand re-opening ceremony today to honor the scientific legacy of the Foundation’s co-founder, Dr. Baruch Blumberg who won the Nobel Prize for his discovery of the hepatitis B virus. Featured guest speaker was Mr. Mark Thompson, President and CEO of The New York Times, who is also the son-in-law of the late Dr. Blumberg. Read more.
Synergy Pharmaceuticals Initiates First Phase 3 Clinical Trial of Plecanatide in Patients with Chronic Idiopathic Constipation
Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) today announced the start of the first of two planned phase 3 clinical trials to confirm the safety and efficacy of plecanatide, its lead GC-C agonist and once-daily oral treatment, in adult patients with chronic idiopathic constipation (CIC) Read more...